Effects of pretreatment with non hypotensive dose of ramiprilat and losartan on myocardial ischemia-reperfusion induced arrhythmias and infarct size in rats

Physiology and Pharmacology

Volumn 15, Issue 1, 2011, Pages 116-123

  Safari, Fatemeh ^a   Hajizadeh, Sohrab ^a   Shekarforoush, Shahnaz ^b   Forouzandeh, Mehdi ^a   Foadoddini, Mohsen ^c   Bayat, Gholamreza ^a   Houshmand, Bita ^a   Khoshbaten, Ali ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arrhythmia; Infarct; Ischemia reperfusion injury; Losartan; Ramiprilat

Indexed keywords

LOSARTAN; RAMIPRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; LEFT CORONARY ARTERY; MALE; NONHUMAN; RAT; TREATMENT DURATION;

EID: 79957934814     PISSN: 17350581     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Barrera A, Turner CG, Angiotensin II receptor blockers. BUMC Proceedings 16 (2003) 123-126.
2. Costerousse O, Allegrini J, Clozel JP and Nard J, Angiotensin I-Converting Enzyme Inhibition but not Angiotensin II suppression alters Angiotensin IConverting Enzyme gene expression in vessels and epithelia. J Pharmacol Exp The 284 (1998) 1180-1187.
3. Foadoddini M, Esmailidehaj M, Mehrani H, Sadraei SH, Golmanesh L, Wahhabaghai H, Valen G, Khoshbaten A Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. Eur J Cardiothorac Surg (2010) Article in press.
4. Hartman JC, The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Ann Thorac Surg 60 (1995) 789-92.
5. Hartman JC, Wall TM, Hullinger TG, Shebuski RJ, Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by bradykinin antagonist HOE140. J Cardiovasc Pharmacol 21 (1993) 996-1003.
6. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. N Engl J Med 342 (2000)145-153.
7. Lang SA, Wolf B, Schober K, Wunderlich C and Marquetant R, Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC expression in the mouse heart. J Cardiovasc Pharmacol 49 (2007) 46-55.
8. Laribi EM, Gharhbili VG, Pizard A, Vincent MP, Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia. J Pharmacol Exp The 323(2007) 210-216.
9. Larkin JE, Frank BC, Gaspard RM, Duka I, Gavras H, Quackenbush J: Cardiac transcriptional response to acute and chronic angiotensin? treatments. Physiol Genomics 18 (2004) 152-166.
10. Logue SE, Gustafsson AB, Samali A: Ischemia - reperfusion injury at the intersection with cell death. J Mol Cell Cardiol 38 (2005) 21-33.
11. Matsuhisha S, Otani H, Okazaki T, Yamashita K, Akita Y, Angiotensin II type I receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt - sensitive rat heart. Am J Physiol Heart Circ Physiol 294 (2008) H2473-2479.
12. Maximal Individual Therapy of Acute Myocardial Infarction PLUS: MITRA PLUS. N Engl J Med 342 (2000) 145-153.
13. McMurray JJV, ACE inhibitors in cardiovascular disease unbeatable? N Engl J Med 358 (2008)1615-166-16.
14. ONTARGET Investigators. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559.
15. Ozer MK, Sahna E, Birincioglu, Acet A: Effects of captopril and losartan on myocardial ischemiareperfusion induced arrhythmias and necrosis in rats. Pharmacol Res 45 (2002) 257-263.
16. Paul M, Poyan Mehr A, Kreutz R, Physiology of local Renin-Angiotensin Systems. Physiol Rev 86 (2006) 747-803.
17. Pilote L, Abrahamowiez M, Eisenberg M, Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ 178 (2008) 1303-11.
18. Sandmann S J Li, Fritzenkotter C, Differential effects of telmesartan and ramipril on inflammatory response after myocardial infarction in rats. Blood Press 15 (2006) 116-128.
19. Schulz R, Heusch G, AT1- receptor blockade in experimental myocardial ischemia/reperfusion. JRAAS 2 (2001) 136-140.
20. Shawn C. Black, Edward M. Driscoll, Benedict R. Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion. Pharmacol 57 (1998) 35-46.
21. Sladek T, Sladkova J, Kolar F, The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovas Res 31 (1996) 568-76.
22. Unger T, Targeting cardiovascular protection: the concept of dual Renin-Angiotensin system control. Medscape J Med 10 (2008) S4.
23. Unger T, Stoppelhaar M, Rationale for double reninangiotensin- aldostrone system blockade. Am J Cardiol 100 (2007) 25-31.
24. Walker MJ, Hearse DJ, Campbell RW: The lambeth conventions: guidelines for the study of arrhythmias in ischemia infarction and reperfusion. Cardiovas Res 22 (1988) 447-55.
25. Weidenbach R, Schulz R, Gres P, Behrend M, Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT1 antagonisms. Br J Pharmacol 131 (2000) 138-144.
26. Xu Y, Kumar D, Dyck JB, Ford W, Clanachan A, AT1 and AT2 receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol 282 (2002) 1206-1215.
27. Yang XP, Liu YH, Shesely E, Liu F, Carretero OA, Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of ACE inhibitor on myocardial ischemia reperfusion injury. Hypertension 34 (1999) 24-30.
28. Zaman MA, Oparil S, Calhoun DA: Drugs targeting the rennin-angiotensin-aldosterone system. Nature 1 (2002) 621-63039-6.
29. Zhu BQ, Sun YP, Sievers RE, Browne A, Lee R, Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. JRAAS 2 (2001) 129-33.